Skip to content

Sebastiano Buti

  • MD PhD
  • University Hospital of Parma
  • 13h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 507CitationsNumber of citations received by Sebastiano's publications. Updated daily.

Publications (5)

  • A new prognostic model for localized renal cell carcinoma

    • Buti S
    N/AReaders
    0Citations
    Get full text
  • Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?

    • Iacovelli R
    • De Giorgi U
    • Galli L
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

    • Bracarda S
    • Galli L
    • Maruzzo M
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

    • Procopio G
    • Prisciandaro M
    • Iacovelli R
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: The GRANT score applied to the ASSURE trial population

    • Buti S
    • Puligandla M
    • Bersanelli M
    • et al.
    N/AReaders
    1Citations
    Get full text

Professional experience

Azienda Ospedaliero Universitaria di Parma